.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Cerilliant
Express Scripts
Teva
Daiichi Sankyo
McKesson
Novartis
Federal Trade Commission
Accenture
Boehringer Ingelheim

Generated: September 22, 2017

DrugPatentWatch Database Preview

NATEGLINIDE Drug Profile

« Back to Dashboard

Which patents cover Nateglinide, and when can generic versions of Nateglinide launch?

Nateglinide is a drug marketed by Zydus Pharms Usa Inc, Alvogen Malta, Dr Reddys Labs Ltd, Watson Labs, Par Pharm, and Teva Pharms. and is included in six NDAs.

The generic ingredient in NATEGLINIDE is nateglinide. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the nateglinide profile page.

Summary for Tradename: NATEGLINIDE

Patents:0
Applicants:6
NDAs:6
Suppliers / Packagers: see list11
Bulk Api Vendors: see list54
Clinical Trials: see list23
Patent Applications: see list4,213
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NATEGLINIDE at DailyMed

Pharmacology for Tradename: NATEGLINIDE

Drug ClassGlinide
Mechanism of ActionPotassium Channel Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc
NATEGLINIDE
nateglinide
TABLET;ORAL205248-001Jul 6, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
NATEGLINIDE
nateglinide
TABLET;ORAL077462-001Mar 30, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
NATEGLINIDE
nateglinide
TABLET;ORAL205055-002Dec 11, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
NATEGLINIDE
nateglinide
TABLET;ORAL077467-002Sep 9, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
NATEGLINIDE
nateglinide
TABLET;ORAL077462-002Mar 30, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
NATEGLINIDE
nateglinide
TABLET;ORAL205248-002Jul 6, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
NATEGLINIDE
nateglinide
TABLET;ORAL205055-001Dec 11, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
NATEGLINIDE
nateglinide
TABLET;ORAL077461-002Sep 9, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
NATEGLINIDE
nateglinide
TABLET;ORAL077461-001Sep 9, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
NATEGLINIDE
nateglinide
TABLET;ORAL077463-002Sep 9, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Healthtrust
US Army
Cerilliant
Covington
QuintilesIMS
McKesson
Accenture
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot